Clinical Trial Update: A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating subcutaneous blinatumomab with low-intensity chemotherapy for older patients with newly diagnosed B-cell acute lymphoblastic leukemia. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING